Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors (Q42996328)

12 November 2017

Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors (English)

1 reference

12 November 2017

1 reference

Aswad S

1

1 reference

12 November 2017

Khan NS

2

1 reference

12 November 2017

Comanor L

3

1 reference

12 November 2017

Chinchilla C

4

1 reference

12 November 2017

Corado L

5

1 reference

12 November 2017

Mone T

6

1 reference

12 November 2017

Mendez R

7

1 reference

12 November 2017

Mendez R

8

1 reference

12 November 2017

1 November 2005

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

12

1 reference

12 November 2017

6

1 reference

12 November 2017

627-634

1 reference

A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

The epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Cadaver donor screening for infectious agents in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood‐donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Hepatitis C infection in cadaver organ donors: strategies to reduce transmission of infection and prevent organ waste

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

HIV and hepatitis C virus RNA in seronegative organ and tissue donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription-Mediated Amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Detection of a healthy carrier of HCV with no evidence of antibodies for over four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

HCV viral load in anti‐HCV‐reactive donors and infectivity for their recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00632.X

10.1111/J.1365-2893.2005.00632.X

21 January 2018

Identifiers

DOI

1 reference

release_jr6oez4xmjbrnfwlyxjh7ybne4

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jr6oez4xmjbrnfwlyxjh7ybne4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference